The Policy & Research Group

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, The Policy & Research Group sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 4 currently recruiting 4 completed top decile by trial count

The Policy & Research Group: 9 sponsored US clinical trials, 4 recruiting.

The Policy & Research Group sponsors 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Teen Pregnancy Prevention, with 6 trials.

Top-decile sponsor footprint

The Policy & Research Group ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the The Policy & Research Group pipeline

4 recruiting of 9 indexed (44% open); 4 completed (44%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Teen Pregnancy Prevention (6 trials), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The Policy & Research Group: open-pipeline peers nationwide

Peers matched on 9 registered trials and 44% open enrollment, not the therapeutic-area sidebar.

The Policy & Research Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 51015202530 0%10%20%30%40%50% Total trials Recruiting share The Policy & Research Group4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyAmerican Heart AssociationAscendis Pharma A/SCullinan TherapeuticsMarquette University
The Policy & Research Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The Policy & Research Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 44% open enrollment (± trial volume)

What to do with this The Policy & Research Group page

9 registered trials is a research-attention snapshot, not an endorsement of The Policy & Research Group or any single study.

  • 4 of The Policy & Research Group's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Teen Pregnancy Prevention is the condition The Policy & Research Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Teen Pregnancy Prevention trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The Policy & Research Group pipeline card: 9 registered trials from official public datasets.Report a data error.